S. Sugarman
Impact in
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
Papers in
- Oncology 13
- Cancer Treatment and Pharmacology 9
- Lung Cancer Research Studies 2
- Neutropenia and Cancer Infections 2
- HER2/EGFR in Cancer Research 2
-
- Breast Cancer Treatment Studies 5
- Cancer Genomics and Diagnostics 1
- Co-authors
- Richard Pazdur (3 shared papers)Yehuda Z. Patt (2 shared papers)Yvonne Lassere (2 shared papers)Jaffer A. Ajani (2 shared papers)James L. Abbruzzese (2 shared papers)Avi B. Markowitz (2 shared papers)Verna A. Rhodes (1 shared paper)C. Hudis (3 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Cancer Research (3 papers)Experimental Biology and Medicine (1 paper)Breast Cancer Research and Treatment (1 paper)Annals of Oncology (1 paper)
- Partner nations
- United StatesSingapore
In The Last Decade
S. Sugarman
16 papers receiving 395 citations
Peers
Comparison fields: 5 of 46
- Oncology 285
- Cancer Research 38
- Pulmonary and Respiratory Medicine 74
- Pathology and Forensic Medicine 38
- Hepatology 16
Countries citing papers authored by S. Sugarman
This map shows the geographic impact of S. Sugarman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Sugarman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Sugarman more than expected).
Fields of papers citing papers by S. Sugarman
This network shows the impact of papers produced by S. Sugarman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Sugarman. The network helps show where S. Sugarman may publish in the future.
Co-authors
The 25 scholars most cited alongside S. Sugarman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 170 | |
| 2 | 2008 | 50 | |
| 3 | 1994 | 44 | |
| 4 | 1996 | 33 | |
| 5 | 2000 | 32 | |
| 6 | 2016 | 20 | |
| 7 | Phase I clinical and plasma and cellular pharmacological study of topotecan without and with granulocyte colony-stimulating factor. | 1996 | 16 |
| 8 | 2006 | 13 | |
| 9 | 2009 | 11 | |
| 10 | 2011 | 7 | |
| 11 | 2007 | 5 | |
| 12 | 2009 | 2 | |
| 13 | 2009 | 2 | |
| 14 | 1995 | 2 | |
| 15 | 1968 | 2 | |
| 16 | 2008 | 1 |
About S. Sugarman
S. Sugarman is a scholar working on Oncology, Cancer Research, Molecular Biology, Cardiology and Cardiovascular Medicine and Dermatology, having authored 16 papers that have together received 410 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (9 papers), Breast Cancer Treatment Studies (5 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers), Lung Cancer Research Studies (2 papers), Cancer therapeutics and mechanisms (2 papers), Neutropenia and Cancer Infections (2 papers), HER2/EGFR in Cancer Research (2 papers) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Oncology (285 citations), Cancer Research (38 citations), Pulmonary and Respiratory Medicine (74 citations), Pathology and Forensic Medicine (38 citations) and Hepatology (16 citations). S. Sugarman has collaborated with scholars based in United States and Singapore. Frequent co-authors include Richard Pazdur, Yehuda Z. Patt, Yvonne Lassere, Jaffer A. Ajani, James L. Abbruzzese, Avi B. Markowitz, Verna A. Rhodes, C. Hudis, Robert G. Johnson and J. L. Abbruzzese. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Experimental Biology and Medicine, Breast Cancer Research and Treatment and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.